January 13, 2020 Liq. Handling & Robotics M&A, Partnerships

Waters to Acquire Andrew Alliance

Waters enables core product portfolio with next-generation automation technology MILFORD, Mass.–(BUSINESS WIRE)–Jan. 13, 2020– Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling... Read more

February 8, 2019 Liq. Handling & Robotics M&A, Partnerships Product Launch

Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research

Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories. Andrew Alliance S.A. and Sartorius today announced the launch of the Andrew Alliance Pipette+ system, which uniquely provides both full traceability and improved repeatability in manual pipetting for life science laboratories. Andrew Alliance, the robotics company... Read more

February 7, 2019 Chromatography Lab Top-10 M&A, Partnerships Mass Spectrometry

Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research

GENEVA, February 6, 2019 /PRNewswire/ — New Liquid Chromatography and Mass Spectrometry Tools Through New Partnership  Andrew Alliance S.A., the robotics company that is improving repeatability with an innovative approach to liquid handling using conventional laboratory pipettes, and Waters Corporation (NYSE: WAT), today announced a new strategic partnership agreement to improve laboratory operations in the... Read more

June 8, 2017 Chromatography Lab Top-10 Liq. Handling & Robotics M&A, Partnerships Mass Spectrometry

Waters and Andrews Alliance Sign Co-Marketing Agreement: Firms to Co-Market New Semi-Automated Sample Preparation Approach for Protein Therapeutics Glycosylation Profiling

Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that... Read more

May 16, 2017 Liq. Handling & Robotics PR/Corporate

Andrew Alliance Awarded Top 100 Most Innovative Companies in Europe- Red Herring

Andrew – The Pipetting Robot – Technology Video AMSTERDAM, May 16, 2017 /PRNewswire/ — Andrew Alliance has been awarded the Red Herring Europe recognition, a prestigious award that positions the company among the top 100 emerging private organizations across all industries on the continent. “In 2017, selecting the top achievers was by no means a small feat,”... Read more